EDOC:NSD-Global X Telemedicine & Digital Health ETF (USD)

ETF | Others |

Last Closing

USD 9.323

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-2.84 (-5.75%)

USD 50.95B
QQQM Invesco NASDAQ 100 ETF

-10.37 (-5.29%)

USD 39.48B
JEPQ JPMorgan Nasdaq Equity Premium..

-2.54 (-4.89%)

USD 22.06B
ACWI iShares MSCI ACWI ETF

-4.49 (-3.82%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

-0.15 (-0.85%)

USD 16.14B
SNDK Sandisk Corp

-9.41 (-19.74%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.01%)

USD 5.17B
NVDL GraniteShares 1.5x Long NVDA D..

-5.93 (-15.45%)

USD 3.76B
TSLL Direxion Shares ETF Trust - Di..

-1.24 (-11.00%)

USD 3.11B
ETHA iShares Ethereum Trust ETF

-0.96 (-6.63%)

USD 2.37B

ETFs Containing EDOC

HDOC:CA 98.44 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.16% 31% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.16% 31% F 52% F
Trailing 12 Months  
Capital Gain 2.00% 59% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.00% 41% F 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -13.49% 11% F 18% F
Dividend Return -13.49% 10% F 18% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.24% 36% F 82% B
Risk Adjusted Return -83.04% 4% F 6% D-
Market Capitalization 0.04B 51% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.